Cargando…

Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma

CD133 is currently believed to be one of the best colorectal cancer stem cell markers. This study aimed to evaluate prognostic significance of CD133 expression in colorectal cancer patients. A total of 303 patients with stage I to III colorectal cancer who underwent curative surgical resection from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Youn Young, An, Chang Hyeok, Oh, Seong Taek, Chang, Eun Deock, Lee, Jaeim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708874/ https://www.ncbi.nlm.nih.gov/pubmed/31393377 http://dx.doi.org/10.1097/MD.0000000000016709

Ejemplares similares

Higher percentage of CD133(+ )cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
por: Li, Chun-Yan, et al.
Publicado: (2009)

Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
por: Pradhan, Tapas, et al.
Publicado: (2019)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy
por: Mia-Jan, Khalilullah, et al.
Publicado: (2013)

Use of gentamicin-collagen sponge (Collatamp(®) G) in minimally invasive colorectal cancer surgery: A propensity score-matched study
por: Lee, Kil-yong, et al.
Publicado: (2022)

Short-Term Impact of Temporary Shutdown of a University-Affiliated Hospital on Patients With Colorectal Cancer During the Coronavirus Disease 2019 Pandemic
por: Park, Youn Young, et al.
Publicado: (2022)

Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
por: Li, Wanlu, et al.
Publicado: (2017)

The effect of circular stapler size on anastomotic stricture formation in colorectal surgery: A propensity score matched study
por: Lee, Kil-yong, et al.
Publicado: (2023)

Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
por: Hashimoto, Kousuke, et al.
Publicado: (2013)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies
por: Huang, Rongyong, et al.
Publicado: (2018)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies: Erratum
Publicado: (2018)

CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Shicai, et al.
Publicado: (2013)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
por: Cai, Xiaobo, et al.
Publicado: (2018)

Routine colonoscopy may be needed for uncomplicated acute right colonic diverticulitis
por: Lee, Kil-yong, et al.
Publicado: (2021)

Routine antibiotics may not be needed to treat uncomplicated right diverticulitis: A retrospective cohort study
por: Lee, Kil-yong, et al.
Publicado: (2021)

Effect of the COVID-19 pandemic on surgical treatment of acute appendicitis: A single-center retrospective study
por: Lee, Kil-yong, et al.
Publicado: (2021)

Advantages of using a polymeric clip versus an endoloop during laparoscopic appendectomy in uncomplicated appendicitis: a randomized controlled study
por: Lee, Kil-yong, et al.
Publicado: (2023)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

CD133 Expression in the Nucleus Is Associated with Endometrial Carcinoma Staging and Tumor Angioinvasion
por: Pietrus, Milosz, et al.
Publicado: (2021)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study
por: HE, AINA, et al.
Publicado: (2012)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

CD133 expression in different stages of gastric adenocarcinoma
por: Boegl, M, et al.
Publicado: (2009)

Difference in Clinical Features between Right- and Left-Sided Acute Colonic Diverticulitis
por: Lee, Kil-yong, et al.
Publicado: (2020)

Downregulation of miR‐133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
por: Chen, Xiaonan, et al.
Publicado: (2016)

DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
por: Cheah, Phaik-Leng, et al.
Publicado: (2018)

Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer
por: Kaidi, Donia, et al.
Publicado: (2022)

Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma
por: Caspa Gokulan, Ravindran, et al.
Publicado: (2021)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
por: Chen, Yao-Li, et al.
Publicado: (2017)

Mesh size may not affect recurrence in laparoscopic totally extraperitoneal repair of inguinal hernias
por: Lee, Kil-yong, et al.
Publicado: (2022)

Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer
por: NAGAYOSHI, KINUKO, et al.
Publicado: (2015)

Low Level of Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II Colorectal Cancer Patients
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2016)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Reply: CD133 expression in different stages of gastric adenocarcinoma
por: Smith, L M, et al.
Publicado: (2009)

Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy
por: Allen, Wendy L., et al.
Publicado: (2018)

Preoperative thrombocytosis predicts prognosis in stage II colorectal cancer patients
por: Lee, Yong Sun, et al.
Publicado: (2016)

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
por: Hagiwara, S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vvvqknac9cna84fae7749q5hq7